Montanova Capital (ABEO) reports 0.9% beneficial stake in Abeona Therapeutics

Rhea-AI Filing Summary

Montanova Capital, LLC and Aaron Cowen report their beneficial ownership of Abeona Therapeutics Inc. common stock on an amended Schedule 13G. They each report beneficial ownership of 500,000 shares of common stock, representing 0.9% of the outstanding class.

Both reporting persons have shared voting and dispositive power over 500,000 shares and no sole voting or dispositive power. They indicate that they now hold 5 percent or less of the class. Each reporting person disclaims beneficial ownership of the securities beyond any pecuniary interest.

Key Figures

Shares beneficially owned: 500,000 shares Ownership percentage: 0.9% Shares beneficially owned: 500,000 shares +3 more

6 metrics

Shares beneficially owned 500,000 shares Beneficial ownership reported by Montanova Capital, LLC

Ownership percentage 0.9% Percent of Abeona common stock class held by Montanova Capital, LLC

Shares beneficially owned 500,000 shares Beneficial ownership reported by Aaron Cowen

Ownership percentage 0.9% Percent of Abeona common stock class held by Aaron Cowen

Shared voting power 500,000 shares Shares over which each reporting person has shared voting power

Sole voting power 0 shares Shares over which each reporting person has sole voting authority

Key Terms

beneficial ownership, shared voting power, shared dispositive power, pecuniary interest, +1 more

5 terms

beneficial ownership financial

"Amount beneficially owned: Montanova Capital, LLC - 500,000 Aaron Cowen - 500,000"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"Shared Voting Power 500,000.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 500,000.00"

pecuniary interest financial

"disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest"

control person financial

"Exhibit B - Control Person Identification"

A control person is an individual or entity that can significantly influence a company’s decisions and direction through ownership, voting power, or contractual rights—think of them as the captain who can steer the ship. Investors care because a control person’s choices affect corporate strategy, board appointments, and transactions that can raise or lower a stock’s value, and they often carry additional legal responsibilities and disclosure requirements to protect other shareholders.

FAQ

What ownership in Abeona Therapeutics Inc. (ABEO) does Montanova Capital report?

Montanova Capital reports beneficial ownership of 500,000 shares of Abeona Therapeutics common stock, representing 0.9% of the class, with shared voting and shared dispositive power over all of these shares.

How much of Abeona Therapeutics (ABEO) stock does Aaron Cowen beneficially own?

Aaron Cowen reports beneficial ownership of 500,000 shares of Abeona Therapeutics common stock, equal to 0.9% of the class, with shared voting and dispositive power and no sole voting or dispositive authority.

Does Montanova Capital still own more than 5% of Abeona Therapeutics (ABEO)?

No. The filing indicates ownership of 5 percent or less of Abeona’s common stock. Montanova Capital’s reported beneficial ownership is 0.9% of the outstanding common stock class.

What voting and dispositive powers do the ABEO reporting persons have?

Both Montanova Capital and Aaron Cowen report 0 shares with sole voting or dispositive power and 500,000 shares with shared voting power and 500,000 shares with shared dispositive power over Abeona common stock.

Where are Montanova Capital and Abeona Therapeutics (ABEO) based according to this filing?

Abeona’s principal executive offices are at 6555 Carnegie Avenue, 4th Floor, Cleveland, OH 44103. Montanova Capital’s principal business office is at 11 E 26th Street, 16th Floor, New York, NY 10010.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:30 PM Accepted by SEC EDGAR 08/14/2026 - 04:25 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Abeona Therapeutics Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

00289Y206

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 00289Y206

1

Names of Reporting Persons

Montanova Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 500,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 500,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

500,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.9 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): 00289Y206

1

Names of Reporting Persons

Aaron Cowen

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 500,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 500,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

500,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.9 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Abeona Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 6555 Carnegie Avenue, 4th Floor, Cleveland, OH 44103
Item 2.
(a)	Name of person filing: Montanova Capital, LLC Aaron Cowen
(b)	Address or principal business office or, if none, residence: Montanova Capital, LLC 11 E 26th Street, 16th Floor New York, New York 10010 United States of America Aaron Cowen c/o Montanova Capital, LLC 11 E 26th Street, 16th Floor New York, New York 10010 United States of America
(c)	Citizenship: Montanova Capital, LLC - Delaware Aaron Cowen - United States
(d)	Title of class of securities: Common Stock, $0.01 par value
(e)	CUSIP No.: 00289Y206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Montanova Capital, LLC - 500,000 Aaron Cowen - 500,000
(b)	Percent of class: Montanova Capital, LLC - 0.9% Aaron Cowen - 0.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Montanova Capital, LLC - 0 Aaron Cowen - 0
	(ii) Shared power to vote or to direct the vote: Montanova Capital, LLC - 500,000 Aaron Cowen - 500,000
	(iii) Sole power to dispose or to direct the disposition of: Montanova Capital, LLC - 0 Aaron Cowen - 0
	(iv) Shared power to dispose or to direct the disposition of: Montanova Capital, LLC - 500,000 Aaron Cowen - 500,000
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Please see Exhibit B attached hereto.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Montanova Capital, LLC

Signature:	/s/ Andrew Nathanson
Name/Title:	Andrew Nathanson, General Counsel and Chief Compliance Officer
Date:	08/14/2026

Aaron Cowen

Signature:	/s/ Aaron Cowen
Name/Title:	Aaron Cowen
Date:	08/14/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification